0QNV.L - Addex Therapeutics Ltd

LSE - LSE Delayed price. Currency in CHF
Currency in CHF

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.67
52-week change 3N/A
S&P500 52-week change 36.21%
52-week high 30.0000
52-week low 30.0000
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 526.37M
Implied shares outstanding 6N/A
Float 822.43M
% held by insiders 18.87%
% held by institutions 19.28%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Mar 2023


Profit margin 0.00%
Operating margin (ttm)-1,007.43%

Management effectiveness

Return on assets (ttm)-85.87%
Return on equity (ttm)-204.24%

Income statement

Revenue (ttm)1.7M
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)105.80%
Gross profit (ttm)1.44M
EBITDA -17.21M
Net income avi to common (ttm)-17.39M
Diluted EPS (ttm)-0.5260
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.59M
Total cash per share (mrq)0.09
Total debt (mrq)259.12k
Total debt/equity (mrq)6.36
Current ratio (mrq)2.17
Book value per share (mrq)0.06

Cash flow statement

Operating cash flow (ttm)-13.95M
Levered free cash flow (ttm)-7.52M